[1]
Israr Ahmad, “Comparative Risk of Clinically Significant Bleeding In Patients with Atrial Fibrillation Receiving Factor Xa Inhibitors versus Vitamin K Antagonists: A Case-Control Study”, IJPRT, vol. 16, no. 1, pp. 4774–4779, Jun. 2026.